<DOC>
	<DOCNO>NCT01551979</DOCNO>
	<brief_summary>The aim study look effectiveness repetitive transcranial magnetic stimulation ( rTMS ) therapeutic intervention patient schizophrenia . The primary outcome improvement negative symptom relate schizophrenia . The investigator focus negative symptom give great resistance pharmacological establish therapy . If investigator trial show beneficial effect , clinical significance would great .</brief_summary>
	<brief_title>Therapeutic Efficacy Transcranial Magnetic Stimulation Schizophrenia</brief_title>
	<detailed_description>This study build result previous phase 1 , single-site study demonstrate safety image-guided theta burst stimulation ( TBS ) form rTMS cerebellar vermis ( Demirtas-Tatlidede et al. , 2010 ) eigh patient schizophrenia . The primary goal present study ass efficacy iTBS cerebellar vermis positive negative symptom schizophrenia . A second , add goal investigate mechanism expect clinical improvement . Schizophrenia lead cause mental disability current treatment still remain partially successful many patient . Our underlying hypothesis modulation cerebellar vermis may enhance activity neural system sub-serve cognition emotion , reestablish disturb cerebellar regulation schizophrenic patient , produce clinical improvement .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Age 1865 year Diagnosis schizophrenia accord DSMIV criterion ( Diagnostic Statistical Manual ) boardcertified psychiatrist Preexisting progressive neurological disorder Prior neurological procedure Previous head injury Change antipsychotic medication last 4 week Been inpatient psychiatry clinic within last month Any axis 1 diagnosis Patients may actively enrol separate intervention study Patients unable undergo brain MRI Any unstable medical condition History seizure , diagnosis epilepsy , history abnormal ( epileptiform_ EEG , family history treatment resistant epilepsy Possible pregnancy . All female participant child bear age require pregnancy test . Any metal brain , skull , elsewhere unless approve responsible MD Any medical device ( ie . cardiac pacemaker , deep brain stimulator , medication infusion pump , cochlear implant , vagal nerve stimulator ) unless otherwise approve responsible MD Substance abuse ( alcohol , amphetamine , cocaine , MDMA [ methylenedioxymethamphetamine ] , ecstasy , PCP [ phencyclidine ] , Angle dust ) dependence within past six month No medication absolute exclusion TMS . Medications review responsible MD decision inclusion make base following : patient 's past medical history , drug dose , history recent medication change duration treatment , combination CNS ( central nervous system ) active drug ( publish TMS guideline review medication consider TMS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>repetitive Transcranial Magnetic Stimulation</keyword>
</DOC>